79 related articles for article (PubMed ID: 17051331)
1. Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor.
Sønder SU; Woetmann A; Odum N; Bendtzen K
Apoptosis; 2006 Dec; 11(12):2159-65. PubMed ID: 17051331
[TBL] [Abstract][Full Text] [Related]
2. Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction.
Sønder SU; Mikkelsen M; Rieneck K; Hedegaard CJ; Bendtzen K
Br J Pharmacol; 2006 May; 148(1):46-53. PubMed ID: 16520746
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression.
Mikkelsen M; Sønder SU; Nersting J; Bendtzen K
Apoptosis; 2006 Apr; 11(4):573-9. PubMed ID: 16528473
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB.
Kato Y; Kamiya H; Koide N; Odkhuu E; Komatsu T; Dagvadorj J; Watarai A; Kondo M; Kato K; Nakamura J; Yokochi T
Immunopharmacol Immunotoxicol; 2014 Jun; 36(3):237-41. PubMed ID: 24852317
[TBL] [Abstract][Full Text] [Related]
5. Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction.
Loan Le TY; Mardini M; Howell VM; Funder JW; Ashton AW; Mihailidou AS
Hypertension; 2012 Jun; 59(6):1164-9. PubMed ID: 22508833
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.
Hansen PR; Rieneck K; Bendtzen K
Immunol Lett; 2004 Feb; 91(2-3):87-91. PubMed ID: 15019274
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway.
Wu F; Xiong ZQ; Mao SH; Hu JM; Wang JQ; Jiang HW; Ding Q
Asian J Androl; 2018; 20(1):24-29. PubMed ID: 28382926
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signalling.
Elinoff JM; Chen LY; Dougherty EJ; Awad KS; Wang S; Biancotto A; Siddiqui AH; Weir NA; Cai R; Sun J; Preston IR; Solomon MA; Danner RL
Cardiovasc Res; 2018 Jan; 114(1):65-76. PubMed ID: 29036418
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone abrogates nuclear factor kappaB-mediated tumor necrosis factor alpha production in human neutrophils via the mineralocorticoid receptor.
Bergmann A; Eulenberg C; Wellner M; Rolle S; Luft F; Kettritz R
Hypertension; 2010 Feb; 55(2):370-9. PubMed ID: 20065153
[TBL] [Abstract][Full Text] [Related]
11. Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity.
Habens F; Srinivasan N; Oakley F; Mann DA; Ganesan A; Packham G
Apoptosis; 2005 May; 10(3):481-91. PubMed ID: 15909110
[TBL] [Abstract][Full Text] [Related]
12. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation?
Mandrekar P; Dolganiuc A; Bellerose G; Kodys K; Romics L; Nizamani R; Szabo G
Alcohol Clin Exp Res; 2002 Nov; 26(11):1609-14. PubMed ID: 12436048
[TBL] [Abstract][Full Text] [Related]
13. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
14. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells.
Singh D; Aggarwal A; Maurya R; Naik S
Phytother Res; 2007 Oct; 21(10):905-13. PubMed ID: 17562568
[TBL] [Abstract][Full Text] [Related]
15. Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression.
Ichikawa H; Nair MS; Takada Y; Sheeja DB; Kumar MA; Oommen OV; Aggarwal BB
Clin Cancer Res; 2006 Oct; 12(19):5910-8. PubMed ID: 17021000
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
18. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.
Takata H; Takeda Y; Zhu A; Cheng Y; Yoneda T; Demura M; Yagi K; Karashima S; Yamagishi M
Diabetes Obes Metab; 2012 Feb; 14(2):155-62. PubMed ID: 21951301
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
